We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+1.06%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$355M
AUM Growth
-$58.3M
Cap. Flow
-$49.6M
Cap. Flow %
-13.96%
Top 10 Hldgs %
19.68%
Holding
1,105
New
222
Increased
181
Reduced
330
Closed
90

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$24.9M
2
RACE icon
Ferrari
RACE
+$19.1M
3
CNH
CNH Industrial
CNH
+$12.3M
4
IVE icon
iShares S&P 500 Value ETF
IVE
+$8.23M
5
UBS icon
UBS Group
UBS
+$5.09M

Sector Composition

Rank Sector Weight
1 Miscellaneous 18.09%
2 Technology 16.07%
3 Consumer Discretionary 9.4%
4 Healthcare 9.16%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCK icon
901
Crown Holdings
CCK
$12.2B
$375 ﹤0.01%
3
CHWY icon
902
Chewy
CHWY
$8.52B
$367 ﹤0.01%
9
HBAN icon
903
Huntington Bancshares
HBAN
$33.8B
$366 ﹤0.01%
25
BUD icon
904
AB InBev
BUD
$156B
$360 ﹤0.01%
6
SPB icon
905
Spectrum Brands
SPB
$1.97B
$355 ﹤0.01%
4
BAH icon
906
Booz Allen Hamilton
BAH
$9.63B
$351 ﹤0.01%
4
SUI icon
907
Sun Communities
SUI
$14.3B
$351 ﹤0.01%
+2
New +$372
VWOB icon
908
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.25B
$349 ﹤0.01%
+5
New +$362
GDX icon
909
VanEck Gold Miners ETF
GDX
$28.3B
$345 ﹤0.01%
+9
New +$306
UDR icon
910
UDR
UDR
$11.2B
$344 ﹤0.01%
+6
New +$341
UAA icon
911
Under Armour
UAA
$2.13B
$340 ﹤0.01%
+20
New +$359
AKBA icon
912
Akebia Therapeutics
AKBA
$250M
$338 ﹤0.01%
471
CLVS
913
DELISTED
Clovis Oncology, Inc.
CLVS
$335 ﹤0.01%
166
IOVA icon
914
Iovance Biotherapeutics
IOVA
$4.24B
$333 ﹤0.01%
20
AZPN
915
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$331 ﹤0.01%
2
SPHD icon
916
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.37B
$330 ﹤0.01%
7
XHR
917
Xenia Hotels & Resorts
XHR
$1.61B
$328 ﹤0.01%
+17
New +$311
RPM icon
918
RPM International
RPM
$12.8B
$326 ﹤0.01%
4
WYNN icon
919
Wynn Resorts
WYNN
$8.93B
$319 ﹤0.01%
+4
New +$337
EXTR icon
920
Extreme Networks
EXTR
$2.88B
$317 ﹤0.01%
26
CXW icon
921
CoreCivic
CXW
$3.5B
$313 ﹤0.01%
28
EPHE icon
922
iShares MSCI Philippines ETF
EPHE
$141M
$311 ﹤0.01%
10
LCII icon
923
LCI Industries
LCII
$2.13B
$311 ﹤0.01%
3
EFV icon
924
iShares MSCI EAFE Value ETF
EFV
$31.7B
$302 ﹤0.01%
6
TROW icon
925
T. Rowe Price
TROW
$22.2B
$302 ﹤0.01%
2

Similar funds

Exane Derivatives's Q1 2022 Portfolio in Review

As of Q1 2022, Exane Derivatives held 1,105 positions worth $355M, down 14% from $413M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Exane Derivatives withdrew a net $49.6M in Q1 2022, closing 90 positions and reducing 330 holdings. Its most notable exit was iShares S&P 500 Value ETF, an estimated $8.23M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Exane Derivatives opened a new position in Visa worth $4.62M.

  • Exane Derivatives's largest Q1 2022 buy was Visa: 20,811 shares worth $4.62M.
  • Exane Derivatives added most to iShares MSCI China ETF in Q1 2022, an estimated $5.54M increase.
  • Exane Derivatives's biggest Q1 2022 reduction was Stellantis, cutting an estimated $24.9M.
  • Exane Derivatives fully exited iShares S&P 500 Value ETF in Q1 2022, selling an estimated $8.23M.
  • Exane Derivatives's ten largest holdings make up 20% of its $355M portfolio in Q1 2022.
  • Exane Derivatives opened 222 new positions and closed 90 in Q1 2022.
  • Exane Derivatives's portfolio value fell 14% quarter-over-quarter to $355M.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.